Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactose is utilized as an inactive placebo control in clinical research conducted by the University of Wisconsin-Madison, specifically within studies investigating human cerebral blood flow (CBF) regulation. In these mechanistic trials, such as those examining sex differences and the effects of hypoxic or hypercapnic stress (e.g., NCT02936687), lactose is administered in pill form to serve as a comparator against active pharmacological agents like indomethacin or hormonal modulators. This experimental design allows researchers to isolate the physiological effects of active interventions on cerebrovascular regulation using advanced MRI techniques in healthy volunteers and specific patient populations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lactose-University of Wisconsin, Madison.